Company: BIAF
Filing Date: 2025-06-27
Form Type: POS AM
Source: 0001641172-25-016923
Chunk: 205

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-06-27
Form: POS AM
Chunk 205
---
ited due to a cashless exercise.

| F-27 |

Restricted Stock Awards

The following table summarizes restricted stock award activity under the 2014 and 2024 Plan:

SUMMARY OF RESTRICTED STOCK AWARD

|                              |     |              |           |   |     |             |      |     |            |           |   |     | As of December 31, 2024 |         |     |          |         |   |
|:-----------------------------|:----|:-------------|----------:|:--|:----|:------------|-----:|:----|:-----------|----------:|:--|:----|:------------------------|--------:|:----|:---------|--------:|:--|
|                              |     | Number       
 of           
 restricted   
 stock awards 
 (RSA)        |           |   |     | Weighted-   
 average     
 grant price |      |     | FMV        
 on         
 grant date |           |   |     | Vested                  
 number                  
 of RSA                  |         |     | Unvested 
 number   
 of RSA   |         |   |
| Balance at December 31, 2023 |     |              |   540,969 |   |     | $           | 2.24 |     | $          | 1,209,400 |   |     |                         | 462,298 |     |          |  78,671 |   |
| Granted                      |     |              |   865,423 |   |     |             | 1.81 |     |            | 1,570,834 |   |     |                         | 517,941 |     |          | 347,482 |   |
| Forfeited                    |     |              |   (77,096 | ) |     |             | 1.80 |     |            |  (139,173 | ) |     |                         |       — |     |          | (77,096 | ) |
| Balance at December 31, 2024 |     |              | 1,329,296 |   |     | $           | 2.24 |     | $          | 2,641,061 |   |     |                         | 980,239 |     |          | 349,057 |   |

During the year ended December 31, 2024, the Company issued restricted stock awards (“RSAs”) for 865,423 shares of